Scorpio Stem Cell Solutions Private Limited - Company Profile

It is a business services private limited company based in Hyderabad, Telangana, India, established in 2014.
2014 Hyderabad, Telangana, India Struck Off
Last Updated:
Access Report
About Scorpio Stem Cell Solutions Private Limited

Scorpio Stem Cell Solutions Private Limited, a struck off private limited company, was established on 26 May 2014 in Hyderabad, Telangana, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74900TG2014PTC094144. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Chintalpani Hemanth Reddy (Director), Deepika Giri (Director). It is based at 6-3-788/36&37/A, 2Nd Floor, Durganagar Colony Ameerpet, Hyderabad, Telangana, 500016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900TG2014PTC094144

  • Registration Number

    094144

  • Incorporation Date

    26 May 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 11 Months
Company report

Scorpio Stem Cell Solutions Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Scorpio Stem Cell Solutions Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Scorpio Stem Cell Solutions Private Limited?
Current Directors
Name Designation Appointment Date Status
Chintalpani Hemanth Reddy Director 26 May 2014 Current
Deepika Giri Director 26 May 2014 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Scorpio Stem Cell Solutions.

Enhance accessibility to Scorpio Stem Cell Solutions's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Scorpio Stem Cell Solutions revenue growth over time
Scorpio Stem Cell Solutions profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Scorpio Stem Cell Solutions?

Unlock access to Scorpio Stem Cell Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Scorpio Stem Cell Solutions?

Unlock and access historical data on people associated with Scorpio Stem Cell Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Scorpio Stem Cell Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scorpio Stem Cell Solutions's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Scorpio Stem Cell Solutions
Recent Activity within the Organization
  • Director Appointment

    Chintalpani Hemanth Reddy was appointed as a Director was appointed as a Director on 26 May 2014 & has been associated with this company since 11 years 11 months . was recorded as a recent event.

  • Director Appointment

    Deepika Giri was appointed as a Director was appointed as a Director on 26 May 2014 & has been associated with this company since 11 years 11 months . was recorded as a recent event.

  • Company Incorporation

    Scorpio Stem Cell Solutions Private Limited was registered on 26 May 2014 with Roc Hyderabad & aged 11 years 11 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Scorpio Stem Cell Solutions Private Limited?

The CIN of Scorpio Stem Cell Solutions Private Limited is U74900TG2014PTC094144.

Where is Scorpio Stem Cell Solutions Private Limited headquartered?

Scorpio Stem Cell Solutions Private Limited is headquartered at 6-3-788/36&37/A, 2Nd Floor, Durganagar Colony Ameerpet, Hyderabad, Telangana, 500016.

When was Scorpio Stem Cell Solutions Private Limited incorporated?

Scorpio Stem Cell Solutions Private Limited was incorporated on 26 May 2014.

Who are the current directors of Scorpio Stem Cell Solutions Private Limited?

The current directors of Scorpio Stem Cell Solutions Private Limited are

What is the primary industry of Scorpio Stem Cell Solutions Private Limited?

The primary industry of Scorpio Stem Cell Solutions Private Limited is Business Services.

Is Scorpio Stem Cell Solutions Private Limited a listed company?

Scorpio Stem Cell Solutions Private Limited is unlisted.

What is the capital structure of Scorpio Stem Cell Solutions Private Limited?

The authorized capital of Scorpio Stem Cell Solutions Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available